About
Nemus develops cannabis-based therapeutics using proprietary technology licensed from the University of Mississippi to optimize clinical effects and reduce adverse events for global markets with unmet medical needs.
Explore Nemus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.